Financials
Financial year 2025
Dr MATHIJS Zissi Endocrino-diabetologue from Le Roeulx, company number BE0834863162, closed financial year 2025 with a result of € 170,489 after tax. For that financial year Dr MATHIJS Zissi Endocrino-diabetologue recorded a gross margin of € 284,296 and equity of € 626,237. Compared with financial year 2024, the result moved from € 207,274 to € 170,489. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 15, 2026.
€ 626,237
▲ 32% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 170,489
▼ 18% vs 2024
Profit after tax over the fiscal year.
€ 156,452
▲ 87% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 20,000 paid out
12 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
€ 13,999
▼ 25% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 99,107
▼ 41% vs 2024
€ 18,332 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 43,680
▲ € 37,051 vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,600
▼ 85% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 188,935 | € 188,140 | € 349,324 | € 284,296 | ▼ 19% |
| Profit after taxes | € 115,623 | € 124,100 | € 207,274 | € 170,489 | ▼ 18% |
| Equity | € 244,374 | € 298,474 | € 475,748 | € 626,237 | ▲ 32% |
| Total debts | € 156,391 | € 139,605 | € 232,542 | € 153,408 | ▼ 34% |
| Cash | € 236,186 | € 18,803 | € 83,713 | € 156,452 | ▲ 87% |
| Land & buildings | € 78,374 | € 354,978 | € 567,262 | € 548,542 | ▼ 3% |
| Retained profit | € 231,974 | € 286,074 | € 463,348 | € 613,837 | ▲ 32% |
| Dividend | € 51,000 | € 70,000 | € 30,000 | € 20,000 | ▼ 33% |
| Bank debt | € 87,918 | € 119,613 | € 167,100 | € 99,107 | ▼ 41% |
| Balance sheet total | € 400,765 | € 438,079 | € 708,290 | € 779,645 | ▲ 10% |
Key figures of Dr MATHIJS Zissi Endocrino-diabetologue, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Dr MATHIJS Zissi Endocrino-diabetologue?
What happened at Dr MATHIJS Zissi Endocrino-diabetologue in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 170,489 (▼ 18% vs 2024). Source: NBB ↗
- New establishment in Le Roeulx. KBO
- Start of the company according to the CBE. KBO
In short
From € 115,623 profit in 2022 to € 170,489 profit in 2025.
Paid € 274,208 in corporate taxes since 2022.
Best year ever: 2024, with € 207,274 profit.
Paid out € 171,000 in dividends to the owners in total.
A new publication or filing at Dr MATHIJS Zissi Endocrino-diabetologue? We notify you, reason included.
Follow Dr MATHIJS Zissi Endocrino-diabetologueDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Establishments
Establishment units
Physical locations of this company
Chaussée de Mons(R) 90
7070 Le Roeulx
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0834.863.162
- VAT number
- BE 0834.863.162
- Registered office
- Chaussée de Mons(R) 90, 7070 Le Roeulx
- Names & denominations
- Dr MATHIJS Zissi Endocrino-diabetologue
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 25 March 2011
- Peppol
- Active · Active since 30 Sept 2025
- Activities · NACE
Activiteiten van medisch specialisten